These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

865 related articles for article (PubMed ID: 26801191)

  • 1. Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.
    Patching SG
    Mol Neurobiol; 2017 Mar; 54(2):1046-1077. PubMed ID: 26801191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited.
    Simpson IA; Appel NM; Hokari M; Oki J; Holman GD; Maher F; Koehler-Stec EM; Vannucci SJ; Smith QR
    J Neurochem; 1999 Jan; 72(1):238-47. PubMed ID: 9886075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose transporters in brain in health and disease.
    Koepsell H
    Pflugers Arch; 2020 Sep; 472(9):1299-1343. PubMed ID: 32789766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose transport in brain - effect of inflammation.
    Jurcovicova J
    Endocr Regul; 2014 Jan; 48(1):35-48. PubMed ID: 24524374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose promoiety enables glucose transporter mediated brain uptake of ketoprofen and indomethacin prodrugs in rats.
    Gynther M; Ropponen J; Laine K; Leppänen J; Haapakoski P; Peura L; Järvinen T; Rautio J
    J Med Chem; 2009 May; 52(10):3348-53. PubMed ID: 19402664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose Transporters in Brain: In Health and in Alzheimer's Disease.
    Szablewski L
    J Alzheimers Dis; 2017; 55(4):1307-1320. PubMed ID: 27858715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose transporters regulation on ischemic brain: possible role as therapeutic target.
    Espinoza-Rojo M; Iturralde-Rodríguez KI; Chánez-Cárdenas ME; Ruiz-Tachiquín ME; Aguilera P
    Cent Nerv Syst Agents Med Chem; 2010 Dec; 10(4):317-25. PubMed ID: 20868355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mismatch between GLUTs and glucose levels causes neuronal damage during glucose fluctuations.
    Xie Z; Guo J; Kang Y; Ou X
    Med Hypotheses; 2018 Mar; 112():37-39. PubMed ID: 29447934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of glucose transporters in human neurodegenerative diseases.
    Głuchowska K; Pliszka M; Szablewski L
    Biochem Biophys Res Commun; 2021 Feb; 540():8-15. PubMed ID: 33429199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation.
    Vemula S; Roder KE; Yang T; Bhat GJ; Thekkumkara TJ; Abbruscato TJ
    J Pharmacol Exp Ther; 2009 Feb; 328(2):487-95. PubMed ID: 18981287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hypoxia-ischemia on GLUT1 and GLUT3 glucose transporters in immature rat brain.
    Vannucci SJ; Seaman LB; Vannucci RC
    J Cereb Blood Flow Metab; 1996 Jan; 16(1):77-81. PubMed ID: 8530559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose transporter 1, distribution in the brain and in neural disorders: its relationship with transport of neuroactive drugs through the blood-brain barrier.
    Guo X; Geng M; Du G
    Biochem Genet; 2005 Apr; 43(3-4):175-87. PubMed ID: 15932065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral glucose transporter: the possible therapeutic target for ischemic stroke.
    Zhang S; Zuo W; Guo XF; He WB; Chen NH
    Neurochem Int; 2014 May; 70():22-9. PubMed ID: 24657444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis.
    Nair KGS; Ramaiyan V; Sukumaran SK
    Inflammopharmacology; 2018 Jun; 26(3):675-684. PubMed ID: 29582240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of glucose transporters in the distribution of p-aminophenyl-α-d-mannopyranoside modified liposomes within mice brain.
    Du D; Chang N; Sun S; Li M; Yu H; Liu M; Liu X; Wang G; Li H; Liu X; Geng S; Wang Q; Peng H
    J Control Release; 2014 May; 182():99-110. PubMed ID: 24631863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain glucose transporters: implications for neurologic disease.
    Benarroch EE
    Neurology; 2014 Apr; 82(15):1374-9. PubMed ID: 24647029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose transporter expression in brain: relationship to cerebral glucose utilization.
    Vannucci SJ; Clark RR; Koehler-Stec E; Li K; Smith CB; Davies P; Maher F; Simpson IA
    Dev Neurosci; 1998; 20(4-5):369-79. PubMed ID: 9778574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A focus on glucose-mediated drug delivery to the central nervous system.
    Serrano ID; Ribeiro MM; Castanho MA
    Mini Rev Med Chem; 2012 Apr; 12(4):301-12. PubMed ID: 22303945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood-brain barrier part III: therapeutic approaches to cross the blood-brain barrier and target the brain].
    Weiss N; Miller F; Cazaubon S; Couraud PO
    Rev Neurol (Paris); 2010 Mar; 166(3):284-8. PubMed ID: 19699499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane transporter proteins: a challenge for CNS drug development.
    Girardin F
    Dialogues Clin Neurosci; 2006; 8(3):311-21. PubMed ID: 17117613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.